| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
[Ala11,D-Leu15]-Orexin B
|
532932-99-3 |
ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-MET-NH2
|
ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-MET-NH2;H-ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-MET-NH2;(Ala11,D-Leu15)-Orexin B (human) trifluoroacetate salt H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln-Arg-Leu-D-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 trifluoroacetate salt;[ALA11,D-LEU15]-OREXIN B;(ALA11,D-LEU15)-OREXIN B (HUMAN);M.W. 2857.28 C120H206N44O35S
|
C120H206N44O35S |
2857.26 | |
|
H-PRO-HYP-OH
|
18684-24-7 |
H-PRO-HYP-OH
|
4-羟基-1-L-脯氨酰-L-脯氨酸
|
C10H16N2O4 |
228.24504 | 242-609-6 |
|
Z-Dbu(Boc)(S)
|
96186-30-0 |
NΓ-BOC-NΒ-Z-D-3,4-二氨基丁酸
|
(3S)-3-{[(benzyloxy)carbonyl]amino}-4-{[(tert-butoxy)carbonyl]amino}butanoic acid;(3S)-4-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(phenylmethoxycarbonylamino)butanoic acid;(R)-4-(BOC-AMINO)-3-(Z-AMINO)BUTYRIC ACID;N-BETA-Z-N-GAMMA-BOC-R-3,4-DIAMINOBUTYRIC ACID;N-BETA-N-GAMMA-BOC-R-3,4-DIAMINOBUTYRIC ACID;N-BETA-BENZYLOXYCARBONYL-N-GAMMA-(TERT-BUTYLOXYCARBONYL)-D-3,4-DIAMINOBUTYRIC ACID;N-BETA-BENZYLOXYCARBONYL-N-GAMMA-(T-BUTYLOXYCARBONYL)-D-3,4-DIAMINOBUTYRIC ACID;Z-D-DBU(BOC)-OH
|
C17H24N2O6 |
352.38 | |
|
N-Methyl-3-pyridinamine
|
18364-47-1 |
3-甲氨基吡啶
|
3-甲氨基吡啶;3-(甲基氨基)吡啶;N-甲基吡啶-3-胺;加替沙星 巴洛沙星中间体;3-甲氨基吡啶 10G
|
C6H8N2 |
108.14112 | 223-091-0 |
|
2-AMINO-4,7-DIHYDRO-5H-THIENO[2,3-C]PYRIDINE-3,6-DICARBOXYLIC ACID 6-TERT BUTYL ESTER 3-ETHYL ESTER
|
193537-14-3 |
6-(叔丁基)-3-乙基-2-氨基-4,7-二氢噻吩[2,3-C]吡啶二甲酸叔丁酯
|
2-氨基-4,7-二氢-5H-噻吩并[2,3-C]吡啶-3,6-二甲酸 6-叔丁酯 3;2-氨基-4,6-二甲酸 6-叔丁;6-(叔丁基)-3-乙基-2-氨基-4,7-二氢噻吩[2,3-C]吡啶二甲酸叔丁酯;2-氨基-4,3-C]吡啶-6-BOC-3-羧酸乙酯;2-氨基-4,6-二甲酸 6-叔丁酯 3-乙酯;2-氨基-6-BOC-4,7-二氢噻吩并[2,3-C]吡啶-3(5H)-乙酸乙酯;6-叔丁基3-乙基2-氨基-4,6(5H)-二羧酸酯;2-氨基-4,5-二氢噻吩并[2,6(7H)-二羧酸-6-叔丁基酯
|
C15H22N2O4S |
326.41118 | 251-156-6 |
|
H-VAL-GLY-OH
|
686-43-1 |
H-VAL-GLY-OH
|
(S)-2-(2-氨基-3-甲基丁酰氨)乙酸;缬氨酰-甘氨酸;(S)-2-(2-氨基-3-甲基丁酰氨)乙酸
|
C7H14N2O3 |
174.19766 | |
|
Hemokinin 1 (mouse)
|
208041-90-1 |
ARG-SER-ARG-THR-ARG-GLN-PHE-TYR-GLY-LEU-MET-NH2
|
血激肽1;HEMOKININ 1 MOUSE>98%
|
C61H100N22O15S |
1413.65 | |
|
(R)-2-(Fmoc-amino)-2-phenylacetic Acid
|
111524-95-9 |
N-芴甲氧羰基-D-苯基甘氨酸
|
FMOC-D-α-苯基甘氨酸;FMOC-D-PHG-OH;FMOC-D-苯甘氨酸;N-芴甲氧羰基-D-苯基甘氨酸;芴甲氧羰酰基D型苯甘氨酸;N-[(9H-芴-9-基甲氧基)羰基]-D-2-苯基甘氨酸;(R)-2-(FMOC-氨基)-2-苯基乙酸
|
C23H19NO4 |
373.40126 | 625-027-0 |
|
FMOC-L-4,4'-BIPHENYLALANINE
|
205526-38-1 |
FMOC-D-4,4'-联苯丙氨酸
|
FMOC-D-4,4'-联苯丙氨酸;FMOC-4-PHENYL-D-PHE-OH;FMOC-D-4,4'-BIPHENYLALANINE;FMOC-D-4,4'-联苯基丙氨酸;3-(4-联苯基)-N-FMOC-D-丙氨酸;FMOC-D-4,4'-BIPHE-OH;N-[(9H-芴-9-甲氧基)羰基]-D-4,4'-联苯丙氨酸;N-[(9H-芴-9-甲氧基)羰基]-D-4;(R)-2-(FMOC-氨基)-3-(4-联苯基)丙酸
|
C30H25NO4 |
463.5238 | |
|
Fmoc-Trp(For)-OH
|
152338-45-9 |
FMOC-N-甲醛-L-色氨酸
|
FMOC-N-甲醛-L-色氨酸
|
C27H22N2O5 |
454.47 | |
|
Fmoc-L-Lys(Boc)-L-Cys[PSI(Dmp,H)pro]-OH
|
955048-89-2 |
(5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸
|
(5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸;FMOC-LEU-THR(ΨME,ME PRO)-OH_ 955048-89-2
|
C28H34N2O6 |
494.58 | |
|
Fmoc-L-Tyr(tBu)-L-Thr[PSI(Me,Me)Pro]-OH
|
920519-31-9 |
(4S)-3-[(2S)-3-[4-(叔丁氧基)苯基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2,5-三甲基-4-恶唑烷羧酸
|
(4S)-3-[(2S)-3-[4-(叔丁氧基)苯基]-2-[[芴甲氧羰基]氨基]-1-氧代丙基]-2,2,5-三甲基-4-恶唑烷羧酸;FMOC-TYR(TBU)-THR(ΨME,ME PRO)-OH_920519-31-9
|
C35H40N2O7 |
600.7 | |
|
FMOC-CYS(ME)-OH
|
138021-87-1 |
N-芴甲氧羰基-S-甲基-L-半胱氨酸
|
FMOC-S-甲基-L-半胱氨酸;N-芴甲氧羰基-S-甲基-L-半胱氨酸
|
C19H19NO4S |
357.42346 | |
|
GALANIN, PORCINE
|
88813-36-9 |
神经节肽(抗原)
|
神经节肽(抗原);神经节肽(抗体)“甘丙肽”;神经节肽;GALANIN PORCINEGALANIN POR;猪甘丙肽(1-29);甘丙肽(猪);甘丙肽(猪),≥97%
|
C146H213N43O40 |
3210.52 | |
|
Neuropeptide W-23 (human(
|
383415-79-0 |
TRP-TYR-LYS-HIS-VAL-ALA-SER-PRO-ARG-TYR-HIS-THR-VAL-GLY-ARG-ALA-ALA-GLY-LEU-LEU-MET-GLY-LEU
|
神经肽 W-23 (人(>95%
|
C119H183N35O28S |
2584.00902 | |
|
Cholesterol oxidase
|
9028-76-6 |
胆固醇氧化酶
|
胆甾醇氧化酶;胆甾醇氧化酶(+4°C);重组胆固醇氧化酶;胆固醇氧化酶;胆甾醇氧化酶;重组胆固醇氧化酶;REC-COD;胆固醇酶;胆固醇氧化酶(短杆菌);胆固醇氧化酶;胆固醇氧化酶(微生物)
|
232-842-1 | ||
|
BIS(4-NITROPHENYL)PHOSPHORIC ACID SODIUM SALT
|
4043-96-3 |
对硝基酚磷酸钠
|
SodiuM Bis(4-nitrophenyl)phosphate ;BIS(P-NITROPHENYL) PHOSPHATE SODIUM SALT;BIS(PNP)-PHOS NA;BIS(4-NITROPHENYL)PHOSPHORIC ACID SODIUM SALT;BIS(4-NITROPHENYL)PHOSPHATE SODIUM SALT;SODIUM BIS(4-NITROPHENYL)PHOSPHATE;bis(P-nitrophenyl)phosphate sodium;Sodium Bis(4-nitrophenyl)phosphate [for Phosphodiesterase Substrate]
|
C12H8N2O8P-.Na+ |
362.16412 | 223-739-2 |
|
(S)-3-AMINO-5-HEXYNOIC ACID HYDROChloride
|
270596-46-8 |
(S)-3-氨基-5-己酸盐酸盐
|
(S)-3-氨基-5-己酸盐酸盐;L-Β-3-氨基-5-己炔酸.盐酸盐;(3S)-3-氨基-5-己炔酸
|
C6H9NO2.HCl |
163.6021 | |
|
Fmoc-3,5-Difluoro-D-Phenylalanine
|
205526-25-6 |
保护的-3,5-二氟苯丙氨酸
|
9-芴甲氧羰基-D-3,5-二氟苯丙氨酸;保护的-3,5-二氟苯丙氨酸;FMOC-3,5-二氟-D-苯丙氨酸
|
C24H19NO4F2 |
423.40876 | |
|
H-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2
|
150138-78-6 |
NEUROPEPTIDE Y (3-36) (HUMAN, RAT)
|
SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2;TYR-PRO-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-LEU-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR: YPSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY;NEUROPEPTIDE Y FRAGMENT 3-36 HUMAN,RAT,≥95% ;NEUROPEPTIDE Y FRAGMENT 3-36 HUMAN,RAT ≥95%;神经肽 Y(3-36)
|
C175H269 N53 O54 S |
4011.4 |










